Latest Atrial septal defect Stories
Provides new insight into the most common form of congenital heart disease.
A novel study by Canadian physicians reported that the BioSTARTM biodegradable implant achieved comparable closure rates to the Amplatzer Septal OccluderTM (ASO) in children with atrial septal defect (ASD).
JENA, Germany, June 24, 2010 /PRNewswire/ -- In 2009 the Patents Court of the High Court, Chancery Division, decided that Occlutech's range of Figulla ASD and PFO occluders do not infringe the U.K. part of European Patent 0 808 138. AGA Medical decided to appeal against this decision. The U.K.
Pediatric Heart Network study is largest clinical trial of treatment of patients with congenital heart disease.
NEW YORK, Nov. 17 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. U.S.
MORRISVILLE, N.C., Nov. 16 /PRNewswire/ -- nContact Surgical, Inc.
JENA, Germany, September 23 /PRNewswire/ -- Occlutech GmbH, the leading European developer of products for septal closure, today announced that the district court of Frankfurt, Germany reversed an earlier court injunction obtained by AGA Medical against Occlutech's sales and marketing activities relating to the newly launched Figulla Flex ranges of ASD and PFO occluders. The district court of Frankfurt reversed its earlier decision that was based on a request by AGA Medical, relying only...
ZURICH, September 21 /PRNewswire/ -- Occlutech AG, the leading European developer of products for septal closure, today announced that, together with its partner in Spain IZASA SA, it defeated a request for an injunction against sales and marketing activities in Spain, launched at the Commercial Court I of Barcelona, Spain by its U.S.
JENA, Germany, May 12 /PRNewswire/ -- Occlutech, the leading European developer of septum occluders, today announced that it has obtained CE mark approval for its new generation ASD and PFO occluders, the Figulla Flex. The Figulla Flex ASD and PFO occluders encompass a new innovative delivery system, making the use of a threaded hub unnecessary.
JENA, Germany, March 19 /PRNewswire/ -- Occlutech GmbH today announced that it had defeated a request for insolvency, launched at the Amtsgericht Gera in Germany by its US competitor AGA Medical. The request by AGA was based on wrongful assumptions about Occlutech, and AGA announced that it had started the said request to recover damages. However, the court - Amtsgericht Gera in Germany - stated, that a proceeding regarding any damages has not yet been started. "Occlutech intends to...
An echocardiogram is a test that, much like an ultrasound, uses sound waves to create a moving image of the heart. The most common type of echocardiogram is performed transthoracic, meaning the image is taken through a probe against the chest. A TTE does not involve radiation and is a very safe procedure. A cardiac sonographer will put a gel on the patient's chest and move the transducer around different areas, including directly anterior to the breastbone, inferior and lateral to the right...
- Large; stout; burly.